GH fragments and their effects on lipolysis and metabolic regulation
Retatrutide is not yet FDA approved, unlike many GLP-1 agonists, retatrutide will most likely be a weekly injection, delivered subcutaneously into the arm, thigh or stomach area in a self-inject pen
They adjust your treatment plan based on its effectiveness
The most common adverse events were headaches, dizziness, weight loss, and anxiety
Metabolic improvements: Additional benefits noted in research settings include reduction in waist circumference, improved lipid profiles, and decreased markers of insulin resistance
Both medications belong to a class of drugs known as GLP-1 receptor agonists , which mimic the effects of the hormone glucagon-like peptide-1